Cargando…
Brain Metastases in Elderly Patients—The Role of Surgery in the Context of Systemic Treatment
In patients with brain metastases (BM), advanced age is considered a negative prognostic factor. To address the potential reasons for that, we assessed 807 patients who had undergone BM resection; 315 patients aged at least 65 years (group A) were compared with 492 younger patients (group B). We ana...
Autores principales: | Proescholdt, Martin, Jünger, Stephanie T., Schödel, Petra, Schebesch, Karl-Michael, Doenitz, Christian, Pukrop, Tobias, Höhne, Julius, Schmidt, Nils-Ole, Kocher, Martin, Schulz, Holger, Ruge, Maximilian, König, Kevin, Goldbrunner, Roland, Grau, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7831306/ https://www.ncbi.nlm.nih.gov/pubmed/33477588 http://dx.doi.org/10.3390/brainsci11010123 |
Ejemplares similares
-
The Management of Brain Metastases—Systematic Review of Neurosurgical Aspects
por: Proescholdt, Martin A., et al.
Publicado: (2021) -
The Debatable Benefit of Gross-Total Resection of Brain Metastases in a Comprehensive Treatment Setting
por: Jünger, Stephanie T., et al.
Publicado: (2021) -
Surgical resection of symptomatic brain metastases improves the clinical status and facilitates further treatment
por: Schödel, Petra, et al.
Publicado: (2020) -
Timing of Development of Symptomatic Brain Metastases from Non-Small Cell Lung Cancer: Impact on Symptoms, Treatment, and Survival in the Era of Molecular Treatments
por: Jünger, Stephanie T., et al.
Publicado: (2020) -
MLTI-03. The relevance of the count of brain metastases for treatment and outcome in NSCLC
por: Reinecke, David, et al.
Publicado: (2021)